Schrodinger Inc (SDGR) financials

NASDAQ · Health Care

$27.14 -9.50% Close Oct 30, 2026 Live

Schrodinger revenue and earnings by year

Schrodinger's revenue was $256 million in the fiscal year to December 31, 2025, up 23.3% from the year before. Net income was -$103 million, -40.4% of revenue. Since the fiscal year to December 31, 2017, revenue has grown 21.0% a year on average.

RevenueNet income
-$200M$0$200M
201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 9 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue256208217181138108866756
Revenue growth23.3%-4.2%19.7%31.2%27.6%26.4%28.4%19.7%—
Gross profit1431321411016663494340
Gross margin55.7%63.6%64.9%55.8%47.6%58.7%57.4%64.4%71.5%
Operating income-167-209-177-147-111-61-39-28-19
Operating margin-65.2%-100.8%-81.9%-81.1%-80.8%-56.4%-45.3%-42.0%-34.2%
Net income-103-18741-149-100-24-25-28-17
Net margin-40.4%-90.2%18.8%-82.4%-72.8%-22.6%-28.7%-42.7%-31.2%
Diluted EPS-$1.41-$2.57$0.54-$2.10-$1.41————
Free cash flow12-165-150-128-7814-28-29-19

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open SDGR in Markets.

How Schrodinger makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
Software$35.5M60.2%
Drug Discovery$23.4M39.8%

See also: SDGR returns

No forecast, no recommendation. This page describes Schrodinger Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.